Female directors are quicker to recall defective medicinal products, finds study

European Pharmaceutical Review wrote an article about research by IT, Analytics and Operations professor Kaitlin Wowak, which suggests that the presence of female directors makes boards more likely to report lower-severity defects and faster to recall products with high-severity problems.

Published

March 31, 2020